Medication Reconciliation Before Ketamine: Making the Full List Useful

Written by Ketamine News Editorial TeamOctober 30, 2026A Day in the Life4 min read

Key takeaways

Include nonprescription drugs, supplements, and substance use.
Sedation and blood-pressure interactions need coordinated review.
Do not hold or stop medicines without the prescriber’s instructions.

Medication reconciliation means establishing what a person actually takes, not merely copying an old prescription list. Before ketamine or esketamine treatment, it can reveal duplicate medicines, conflicting instructions, recent changes, or substances that affect monitoring. A useful list is a communication tool for clinicians. It is not a checklist that allows a patient to decide independently which combinations are safe or which medicine should be stopped to improve a treatment response.

Record actual use rather than an ideal schedule

For each medicine, write the name, strength if known, usual timing, reason for use, and prescribing clinician. Note whether it is taken regularly or only when needed. Include sleep aids, pain medicines, cold remedies, antihistamines, supplements, and products bought online. If remembering names is difficult, bring packaging or ask the pharmacy for a list. Explain discrepancies rather than guessing to make the record appear complete.

The timing of occasional medicines can matter. A tablet taken only before travel or a sleep medicine used the night before treatment may not appear on a routine chart. Record recent changes and missed doses, too. The purpose is not to invite criticism; it is to give the team an accurate basis for decisions. If cost or side effects have changed how a medicine is taken, that belongs in the discussion.

Sedation is a coordination issue

The Spravato prescribing information, FDA, 2025 warns that central nervous system depressants, including benzodiazepines, opioids, and alcohol, may increase sedation with esketamine and calls for close monitoring. This is a safety statement, not an instruction to discontinue those medicines abruptly. Some drugs can cause withdrawal or other harm if stopped suddenly. The clinician responsible for them should be involved before any change is made.

Ask who will provide the final treatment-day instructions and how those instructions will reach other prescribers. A psychiatric clinic and a pain practice may each assume the other has addressed an interaction. Written communication reduces that gap. If instructions conflict, resolve the conflict before dosing rather than choosing whichever seems more convenient. Do not replace a prescribed sedative with alcohol, cannabis, or an over-the-counter product to get through the appointment.

Blood-pressure interactions deserve their own discussion

The esketamine label also identifies psychostimulants and monoamine oxidase inhibitors as reasons for close blood-pressure monitoring. A medication review should therefore consider more than whether a combination makes someone sleepy. Ask whether a current medicine changes the assessment or monitoring plan, and whether the clinician needs information from the doctor who treats hypertension, attention difficulties, or another condition.

A general internet interaction checker cannot determine suitability for an individual session. It may omit the route, dose, clinical setting, or medical history that changes the decision. Our blood-pressure discussion guide explains why baseline measurements and cardiovascular history need context. Avoid taking extra blood-pressure medicine or withholding a stimulant simply to satisfy a guessed rule that the clinic has not actually given.

Do not overinterpret research on treatment response

People may encounter claims that a particular medicine blocks ketamine or that stopping it guarantees a better response. Such statements require careful evidence review, including whether the finding came from a randomized comparison or an observational analysis. A possible association with symptom outcome is different from an established safety interaction. This guide does not recommend medication changes based on those claims, and a clinic should explain the evidence behind any proposed adjustment.

If an adjustment is recommended, ask what benefit is expected, what risks the change introduces, and who will monitor the original condition. A treatment plan should account for anxiety, seizures, pain, sleep, and other problems rather than treating ketamine response as the only outcome that matters. A specialist may decide that maintaining stability outweighs an uncertain theoretical advantage. That is a clinical judgment requiring the full history.

Include substance use without shame

Alcohol, cannabis, nonmedical sedatives, stimulants, and opioids belong in the history because they may affect immediate safety, diagnosis, and the risk-benefit discussion. The FDA warning on compounded ketamine includes concerns about abuse, misuse, and psychiatric events. Honest disclosure helps clinicians assess risk; it should not be replaced by trying to estimate a safe interval from online anecdotes or another person's experience.

Ask how the clinic handles a disclosure on treatment day, including when it might postpone treatment. Clear policies allow patients to report use without feeling pressure to conceal it after paying or traveling. The safety and consent guide offers further questions about monitoring and emergencies. Leave the consultation with one reconciled list, one agreed set of instructions, and a contact for uncertainty between visits. Update the list whenever another clinician changes treatment.

Medical disclaimer: This article provides general education, not diagnosis, individualized treatment advice, or emergency care. Evidence and regulatory statements refer to the dated sources cited, not an exhaustive verification of all changes through October 30, 2026.

Sources

Source access note: The original FDA compounded-ketamine warning address was unavailable during our link check. The linked Hong Kong Drug Office notice reproduces the dated FDA warning; consult the FDA for subsequent updates.